A POSTMORTEM STUDY OF BRAIN NICOTINIC RECEPTORS IN PARKINSONS AND ALZHEIMERS-DISEASE

被引:0
|
作者
RINNE, JO
MYLLYKYLA, T
LONNBERG, P
MARJAMAKI, P
机构
关键词
PARKINSONS DISEASE; ALZHEIMERS DISEASE; DEMENTIA; CHOLINERGIC RECEPTOR; NICOTINIC RECEPTOR; MUSCARINIC RECEPTOR;
D O I
暂无
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Brain nicotinic receptors were studied in the frontal cortex, temporal cortex, hippocampus and caudate nucleus in patients with Parkinson's disease (PD), Alzheimer's disease (AD) and controls. The B(max) and K(d) values of (-)-[H-3]nicotine binding were determined with a Scatchard analysis. The number of nicotinic receptors declined both in PD and in AD patients in all brain areas examined. The K(d) values were unchanged. There was a negative correlation between the degree of dementia in PD patients and the number of nicotinic receptors in the frontal cortex. A similar correlation was seen between the muscarinic/nicotinic receptor ratio in the frontal cortex and the degree of dementia in PD patients. The present findings indicate that nicotinic receptors are affected not only in AD, but also in PD and that dysfunction of the cholinergic system in the frontal cortex is involved in the dementia process in PD.
引用
收藏
页码:167 / 170
页数:4
相关论文
共 50 条
  • [21] PARKINSONS-DISEASE IN PATIENTS WITH ALZHEIMERS-DISEASE
    LEVERENZ, J
    SUMI, SM
    ARCHIVES OF NEUROLOGY, 1986, 43 (07) : 662 - 664
  • [22] THE NEUROPSYCHOLOGY OF ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE
    REID, WGJ
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1986, 16 (01): : 112 - 112
  • [23] CERULOPLASMIN AND TRANSFERRIN CONCENTRATIONS IN ALZHEIMERS-DISEASE, PARKINSONS-DISEASE, AND NORMAL BRAIN
    LOEFFLER, DA
    LEWITT, PA
    JUNEAU, PL
    BIRD, ET
    DEMAGGIO, A
    NEUROLOGY, 1993, 43 (04) : A251 - A251
  • [24] TRANSFERRIN AND TRANSFERRIN RECEPTORS IN NORMAL BRAIN AND IN ALZHEIMERS-DISEASE
    MORRIS, CM
    COURT, JA
    MOSHTAGHIE, AA
    SKILLEN, A
    CANDY, JM
    PERRY, RH
    EDWARDSON, JA
    FAIRBAIRN, A
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1987, 15 (05) : 891 - 892
  • [25] ALTERATIONS OF PHOSPHOLIPID METABOLITES IN POSTMORTEM BRAIN FROM PATIENTS WITH ALZHEIMERS-DISEASE
    NITSCH, R
    PITTAS, A
    BLUSZTAJN, JK
    SLACK, BE
    GROWDON, JH
    WURTMAN, RJ
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1991, 640 : 110 - 113
  • [26] ALTERATIONS IN PARAMETERS OF LIPID-PEROXIDATION IN POSTMORTEM ALZHEIMERS-DISEASE BRAIN
    ANDORN, AC
    BRITTON, RS
    NEUROBIOLOGY OF AGING, 1994, 15 : S125 - S125
  • [27] AMINERGIC SYSTEMS IN ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE
    DAMATO, RJ
    ZWEIG, RM
    WHITEHOUSE, PJ
    WENK, GL
    SINGER, HS
    MAYEUX, R
    PRICE, DL
    SNYDER, SH
    ANNALS OF NEUROLOGY, 1987, 22 (02) : 229 - 236
  • [28] FREQUENCY OF ALZHEIMERS-DISEASE IN A POSTMORTEM STUDY OF PSYCHIATRIC-PATIENTS
    BUHL, L
    BOJSENMOLLER, M
    DANISH MEDICAL BULLETIN, 1988, 35 (03) : 288 - 290
  • [29] BRAIN MUSCARINIC RECEPTOR SUBTYPES ARE DIFFERENTLY AFFECTED IN ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE
    RINNE, JO
    LONNBERG, P
    MARJAMAKI, P
    RINNE, UK
    BRAIN RESEARCH, 1989, 483 (02) : 402 - 406
  • [30] ALZHEIMERS-DISEASE AND PARKINSONS-DISEASE - NEUROPSYCHOLOGICAL DIFFERENTIATION
    LAVERNHE, G
    POLLAK, P
    BRENIER, F
    GAIO, JM
    HOMMEL, M
    PELLAT, J
    PERRET, J
    REVUE NEUROLOGIQUE, 1989, 145 (01) : 24 - 30